No - in essence they have halted all further research on any products within their pipeline - including the ocular stuff.
Given the news is very recent, no decisions or determination has been made around a way forward.
They did advise that at this point they have not decided to wind the company up......not surprising really given this news is fresh off the print.
There immediate focus is to halt all activities with partners etc.
No telling what will happen from here.........
- Forums
- ASX - By Stock
- DLM
- Ann: Conference Call Details - Phase 2 Clinical Trial Results
Ann: Conference Call Details - Phase 2 Clinical Trial Results, page-11
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online